Literature DB >> 2778878

The terminal regions of adenovirus and minute virus of mice DNAs are preferentially associated with the nuclear matrix in infected cells.

J W Bodnar1, P I Hanson, M Polvino-Bodnar, W Zempsky, D C Ward.   

Abstract

The interaction of viral genomes with the cellular nuclear matrix was studied by using adenovirus-infected HeLa cells and minute virus of mice (MVM)-infected A-9 cells. Adenovirus DNA was associated with the nuclear matrix both early and late in infection, the tightest interaction being with DNA fragments that contain the covalently bound 5'-terminal protein. Replicative forms of MVM DNA were also found to be exclusively matrix associated during the first 16 to 20 h of infection; at later times viral DNA species accumulated in the soluble nuclear fraction at different rates, suggesting a saturation of nuclear matrix-binding sites. MVM DNA fragments enriched in the matrix fraction were also derived from the terminal regions of the viral genome. However, only the subset of fragments which possess a covalently bound 5'-terminal protein (i.e., DNA fragments in which the 5' palindromic DNA sequences are in the extended duplex rather than the hairpin conformation) were matrix associated. These observations suggest that the DNA-matrix interactions are, at least in part, mediated by the viral terminal proteins. Since these proteins have previously been shown to be intimately involved in viral DNA replication, our results further indicate that an association with the nuclear matrix may be important for viral genome replication and possibly also for efficient gene transcription.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2778878      PMCID: PMC251051          DOI: 10.1128/JVI.63.10.4344-4353.1989

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  66 in total

1.  On the localization and transport of specific adenoviral mRNA-sequences in the late infected HeLa cell.

Authors:  E Mariman; A M Hagebols; W van Venrooij
Journal:  Nucleic Acids Res       Date:  1982-10-11       Impact factor: 16.971

2.  Adenoviral heterogeneous nuclear RNA is associated with the host nuclear matrix during splicing.

Authors:  E C Mariman; C A van Eekelen; R J Reinders; A J Berns; W J van Venrooij
Journal:  J Mol Biol       Date:  1982-01-05       Impact factor: 5.469

3.  The nuclear matrix is involved in herpes simplex virogenesis.

Authors:  V Bibor-Hardy; M Pouchelet; E St-Pierre; M Herzberg; R Simard
Journal:  Virology       Date:  1982-09       Impact factor: 3.616

Review 4.  Biological properties of the nuclear matrix: steroid hormone binding.

Authors:  E R Barrack; D S Coffey
Journal:  Recent Prog Horm Res       Date:  1982

5.  Organization of DNA replication in Physarum polycephalum. Attachment of origins of replicons and replication forks to the nuclear matrix.

Authors:  J M Aelen; R J Opstelten; F Wanka
Journal:  Nucleic Acids Res       Date:  1983-02-25       Impact factor: 16.971

6.  Genome-linked proteins of viruses.

Authors:  E Wimmer
Journal:  Cell       Date:  1982-02       Impact factor: 41.582

7.  Adenovirus chromatin structure at different stages of infection.

Authors:  E Daniell; D E Groff; M J Fedor
Journal:  Mol Cell Biol       Date:  1981-12       Impact factor: 4.272

8.  Adenovirus DNA is associated with the nuclear matrix of infected cells.

Authors:  H B Younghusband; K Maundrell
Journal:  J Virol       Date:  1982-08       Impact factor: 5.103

Review 9.  The nucleoskeleton: artefact, passive framework or active site?

Authors:  P R Cook
Journal:  J Cell Sci       Date:  1988-05       Impact factor: 5.285

10.  The matrix attachment regions of the chicken lysozyme gene co-map with the boundaries of the chromatin domain.

Authors:  P V Loc; W H Strätling
Journal:  EMBO J       Date:  1988-03       Impact factor: 11.598

View more
  16 in total

1.  Regulated adenovirus mRNA 3'-end formation in a coupled in vitro transcription-processing system.

Authors:  S I Wilson-Gunn; J E Kilpatrick; M J Imperiale
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

2.  Sequences regulating temporal poly(A) site switching in the adenovirus major late transcription unit.

Authors:  J D DeZazzo; E Falck-Pedersen; M J Imperiale
Journal:  Mol Cell Biol       Date:  1991-12       Impact factor: 4.272

3.  Linker insertion mutations in the adenovirus preterminal protein that affect DNA replication activity in vivo and in vitro.

Authors:  J N Fredman; S C Pettit; M S Horwitz; J A Engler
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

4.  Adenovirus DNA replication: the function of the covalently bound terminal protein.

Authors:  R Pronk; M H Stuiver; P C van der Vliet
Journal:  Chromosoma       Date:  1992       Impact factor: 4.316

5.  Topoisomerase II cleavage of herpes simplex virus type 1 DNA in vivo is replication dependent.

Authors:  S N Ebert; S S Shtrom; M T Muller
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

6.  Adenovirus preterminal protein binds to the CAD enzyme at active sites of viral DNA replication on the nuclear matrix.

Authors:  P C Angeletti; J A Engler
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

7.  Tyrosine kinase-dependent release of an adenovirus preterminal protein complex from the nuclear matrix.

Authors:  P C Angeletti; J A Engler
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

8.  Adenovirus and minute virus of mice DNAs are localized at the nuclear periphery.

Authors:  P T Moen; E Fox; J W Bodnar
Journal:  Nucleic Acids Res       Date:  1990-02-11       Impact factor: 16.971

9.  The adenovirus terminal protein influences binding of replication proteins and changes the origin structure.

Authors:  R Pronk; P C van der Vliet
Journal:  Nucleic Acids Res       Date:  1993-05-25       Impact factor: 16.971

10.  Adenovirus precursor to terminal protein interacts with the nuclear matrix in vivo and in vitro.

Authors:  J N Fredman; J A Engler
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.